| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Fetofetal Transfusion | 34 | 2025 | 192 | 9.460 |
Why?
|
| Ultrasonography, Prenatal | 55 | 2025 | 963 | 6.270 |
Why?
|
| Fetoscopy | 50 | 2025 | 439 | 6.170 |
Why?
|
| Fetal Diseases | 24 | 2024 | 446 | 5.890 |
Why?
|
| Pregnancy | 143 | 2025 | 7169 | 4.970 |
Why?
|
| Pregnancy, Twin | 29 | 2025 | 177 | 4.120 |
Why?
|
| Urethral Obstruction | 7 | 2024 | 56 | 3.590 |
Why?
|
| Meningomyelocele | 17 | 2025 | 237 | 3.070 |
Why?
|
| Premature Birth | 14 | 2023 | 384 | 2.980 |
Why?
|
| Neural Tube Defects | 16 | 2024 | 351 | 2.680 |
Why?
|
| Fetal Membranes, Premature Rupture | 7 | 2023 | 60 | 2.570 |
Why?
|
| Laser Coagulation | 10 | 2024 | 129 | 2.520 |
Why?
|
| Fetal Growth Retardation | 10 | 2025 | 240 | 2.480 |
Why?
|
| Gestational Age | 38 | 2025 | 1161 | 2.420 |
Why?
|
| Laser Therapy | 12 | 2023 | 250 | 2.400 |
Why?
|
| Pregnancy Outcome | 28 | 2025 | 589 | 2.360 |
Why?
|
| Infant, Newborn | 59 | 2025 | 8181 | 2.080 |
Why?
|
| Oligohydramnios | 4 | 2025 | 46 | 1.960 |
Why?
|
| Female | 145 | 2025 | 66236 | 1.940 |
Why?
|
| Polycythemia | 4 | 2024 | 43 | 1.870 |
Why?
|
| Delivery, Obstetric | 4 | 2022 | 250 | 1.820 |
Why?
|
| Placenta | 15 | 2023 | 506 | 1.740 |
Why?
|
| Fetus | 20 | 2023 | 584 | 1.700 |
Why?
|
| Perinatal Death | 2 | 2023 | 26 | 1.690 |
Why?
|
| Retrospective Studies | 80 | 2025 | 16228 | 1.650 |
Why?
|
| Prenatal Diagnosis | 15 | 2025 | 597 | 1.580 |
Why?
|
| Amniotic Fluid | 6 | 2025 | 151 | 1.560 |
Why?
|
| Hysterotomy | 14 | 2025 | 126 | 1.530 |
Why?
|
| Fetal Therapies | 8 | 2020 | 72 | 1.530 |
Why?
|
| Placenta Accreta | 10 | 2024 | 155 | 1.500 |
Why?
|
| Humans | 147 | 2025 | 124307 | 1.360 |
Why?
|
| Amniotic Band Syndrome | 2 | 2020 | 24 | 1.360 |
Why?
|
| Urologic Diseases | 3 | 2021 | 45 | 1.350 |
Why?
|
| Twins, Monozygotic | 12 | 2025 | 117 | 1.330 |
Why?
|
| Cesarean Section | 16 | 2021 | 387 | 1.300 |
Why?
|
| Hydrocephalus | 6 | 2024 | 244 | 1.300 |
Why?
|
| Anemia | 3 | 2022 | 339 | 1.280 |
Why?
|
| Hydrops Fetalis | 4 | 2022 | 75 | 1.270 |
Why?
|
| Adult | 64 | 2025 | 29385 | 1.170 |
Why?
|
| Labor, Obstetric | 3 | 2022 | 94 | 1.100 |
Why?
|
| Fetal Heart | 3 | 2017 | 117 | 1.090 |
Why?
|
| Prenatal Care | 9 | 2023 | 348 | 1.080 |
Why?
|
| Abruptio Placentae | 2 | 2023 | 17 | 1.070 |
Why?
|
| Umbilical Arteries | 6 | 2021 | 94 | 1.060 |
Why?
|
| Spina Bifida Cystica | 3 | 2024 | 35 | 1.050 |
Why?
|
| Labor Presentation | 2 | 2022 | 10 | 0.960 |
Why?
|
| Polyhydramnios | 4 | 2025 | 56 | 0.960 |
Why?
|
| Pregnancy Complications | 6 | 2022 | 507 | 0.920 |
Why?
|
| Lasers | 9 | 2024 | 115 | 0.920 |
Why?
|
| Teratoma | 3 | 2024 | 123 | 0.900 |
Why?
|
| Sutures | 1 | 2024 | 67 | 0.870 |
Why?
|
| Pleural Effusion | 3 | 2024 | 101 | 0.870 |
Why?
|
| Indomethacin | 2 | 2021 | 84 | 0.870 |
Why?
|
| Hernias, Diaphragmatic, Congenital | 6 | 2025 | 402 | 0.850 |
Why?
|
| Urinary Tract | 1 | 2023 | 60 | 0.850 |
Why?
|
| Surgical Wound Dehiscence | 2 | 2020 | 51 | 0.840 |
Why?
|
| Gastroschisis | 2 | 2020 | 53 | 0.840 |
Why?
|
| Chorioamnionitis | 1 | 2022 | 42 | 0.800 |
Why?
|
| Neurosurgical Procedures | 4 | 2021 | 307 | 0.770 |
Why?
|
| Labor Stage, Second | 1 | 2021 | 16 | 0.750 |
Why?
|
| Cohort Studies | 19 | 2024 | 4731 | 0.740 |
Why?
|
| Hydronephrosis | 1 | 2021 | 35 | 0.730 |
Why?
|
| Ascites | 1 | 2021 | 88 | 0.720 |
Why?
|
| Postoperative Complications | 7 | 2021 | 3069 | 0.710 |
Why?
|
| Extraembryonic Membranes | 1 | 2020 | 14 | 0.710 |
Why?
|
| Uterine Rupture | 1 | 2020 | 18 | 0.690 |
Why?
|
| Myometrium | 1 | 2020 | 47 | 0.690 |
Why?
|
| Hysterectomy | 7 | 2021 | 192 | 0.680 |
Why?
|
| Polytetrafluoroethylene | 1 | 2020 | 83 | 0.680 |
Why?
|
| Cyclooxygenase Inhibitors | 1 | 2020 | 63 | 0.670 |
Why?
|
| Pregnancy Trimester, Second | 7 | 2024 | 166 | 0.660 |
Why?
|
| Spinal Dysraphism | 5 | 2023 | 267 | 0.660 |
Why?
|
| Kidney | 4 | 2021 | 1345 | 0.660 |
Why?
|
| Ductus Arteriosus | 1 | 2020 | 63 | 0.650 |
Why?
|
| Light Coagulation | 5 | 2023 | 24 | 0.640 |
Why?
|
| Cicatrix | 1 | 2020 | 123 | 0.640 |
Why?
|
| Constriction, Pathologic | 1 | 2020 | 243 | 0.630 |
Why?
|
| Airway Obstruction | 4 | 2023 | 165 | 0.630 |
Why?
|
| Salpingostomy | 1 | 2018 | 1 | 0.630 |
Why?
|
| Ovarian Hyperstimulation Syndrome | 1 | 2018 | 9 | 0.630 |
Why?
|
| Pregnancy, Tubal | 1 | 2018 | 4 | 0.620 |
Why?
|
| Subcutaneous Fat, Abdominal | 1 | 2018 | 2 | 0.620 |
Why?
|
| Meningocele | 1 | 2018 | 19 | 0.610 |
Why?
|
| Organ Sparing Treatments | 1 | 2018 | 35 | 0.600 |
Why?
|
| Pulsatile Flow | 5 | 2021 | 126 | 0.590 |
Why?
|
| Fallopian Tubes | 1 | 2018 | 71 | 0.590 |
Why?
|
| Anthropometry | 1 | 2018 | 197 | 0.570 |
Why?
|
| Ventriculoperitoneal Shunt | 2 | 2019 | 49 | 0.560 |
Why?
|
| Hypertension, Pregnancy-Induced | 1 | 2018 | 74 | 0.560 |
Why?
|
| Placental Circulation | 2 | 2020 | 23 | 0.560 |
Why?
|
| Blood Transfusion, Intrauterine | 3 | 2024 | 37 | 0.550 |
Why?
|
| Magnetic Resonance Imaging | 11 | 2025 | 3575 | 0.550 |
Why?
|
| Edema | 2 | 2022 | 136 | 0.550 |
Why?
|
| Pericardium | 1 | 2017 | 82 | 0.540 |
Why?
|
| Kidney Diseases | 1 | 2021 | 477 | 0.540 |
Why?
|
| Sepsis | 1 | 2021 | 479 | 0.530 |
Why?
|
| Diabetes, Gestational | 1 | 2018 | 112 | 0.530 |
Why?
|
| Heart Neoplasms | 1 | 2017 | 102 | 0.530 |
Why?
|
| Placenta Previa | 4 | 2021 | 65 | 0.520 |
Why?
|
| Arm | 1 | 2016 | 80 | 0.520 |
Why?
|
| Pregnancy in Diabetics | 1 | 2016 | 20 | 0.520 |
Why?
|
| Ovary | 1 | 2018 | 380 | 0.510 |
Why?
|
| Diseases in Twins | 3 | 2021 | 94 | 0.500 |
Why?
|
| Placenta Diseases | 3 | 2022 | 59 | 0.490 |
Why?
|
| Treatment Outcome | 22 | 2025 | 12292 | 0.490 |
Why?
|
| Perinatal Mortality | 3 | 2020 | 43 | 0.480 |
Why?
|
| Young Adult | 20 | 2023 | 8974 | 0.460 |
Why?
|
| Body Mass Index | 1 | 2020 | 1547 | 0.440 |
Why?
|
| Fetal Death | 3 | 2023 | 112 | 0.430 |
Why?
|
| Pregnancy Complications, Infectious | 4 | 2024 | 449 | 0.420 |
Why?
|
| Cerebrovascular Circulation | 1 | 2016 | 433 | 0.410 |
Why?
|
| Watchful Waiting | 2 | 2023 | 68 | 0.410 |
Why?
|
| Urinary Bladder | 3 | 2024 | 244 | 0.410 |
Why?
|
| Blood Loss, Surgical | 5 | 2019 | 152 | 0.400 |
Why?
|
| Pregnancy, Triplet | 2 | 2022 | 10 | 0.400 |
Why?
|
| Ultrasonography | 3 | 2022 | 927 | 0.390 |
Why?
|
| Infant | 14 | 2025 | 12473 | 0.380 |
Why?
|
| Ultrasonography, Doppler | 5 | 2020 | 193 | 0.370 |
Why?
|
| Perinatal Care | 3 | 2022 | 67 | 0.340 |
Why?
|
| Hemangioma | 2 | 2022 | 94 | 0.330 |
Why?
|
| Pregnancy Reduction, Multifetal | 4 | 2022 | 20 | 0.330 |
Why?
|
| Obstetric Labor, Premature | 2 | 2020 | 85 | 0.330 |
Why?
|
| Walking | 2 | 2024 | 212 | 0.330 |
Why?
|
| Magnesium Sulfate | 2 | 2021 | 50 | 0.320 |
Why?
|
| Risk Factors | 13 | 2023 | 10141 | 0.320 |
Why?
|
| Motor Activity | 3 | 2021 | 523 | 0.320 |
Why?
|
| Prospective Studies | 7 | 2023 | 6071 | 0.310 |
Why?
|
| Laparotomy | 3 | 2024 | 135 | 0.300 |
Why?
|
| Odds Ratio | 3 | 2021 | 1246 | 0.300 |
Why?
|
| Fetal Weight | 4 | 2023 | 61 | 0.300 |
Why?
|
| Birth Weight | 5 | 2022 | 348 | 0.290 |
Why?
|
| Neurodevelopmental Disorders | 2 | 2025 | 506 | 0.290 |
Why?
|
| Heart Defects, Congenital | 2 | 2017 | 1817 | 0.290 |
Why?
|
| Carbon Dioxide | 4 | 2023 | 274 | 0.280 |
Why?
|
| Trachea | 4 | 2023 | 201 | 0.270 |
Why?
|
| Incidence | 4 | 2021 | 3080 | 0.270 |
Why?
|
| Education, Graduate | 3 | 2021 | 20 | 0.270 |
Why?
|
| Delphi Technique | 2 | 2024 | 210 | 0.260 |
Why?
|
| Amniocentesis | 2 | 2023 | 78 | 0.250 |
Why?
|
| Lung | 5 | 2025 | 1491 | 0.250 |
Why?
|
| Blood Component Transfusion | 3 | 2021 | 53 | 0.250 |
Why?
|
| ROC Curve | 3 | 2022 | 561 | 0.240 |
Why?
|
| Case-Control Studies | 7 | 2025 | 3266 | 0.240 |
Why?
|
| Congenital Abnormalities | 2 | 2018 | 254 | 0.240 |
Why?
|
| Echocardiography | 3 | 2021 | 1052 | 0.230 |
Why?
|
| Sacrococcygeal Region | 1 | 2024 | 32 | 0.230 |
Why?
|
| Diagnosis, Differential | 2 | 2021 | 1891 | 0.230 |
Why?
|
| Tensile Strength | 1 | 2024 | 39 | 0.230 |
Why?
|
| Polyesters | 1 | 2024 | 40 | 0.230 |
Why?
|
| Materials Testing | 1 | 2024 | 73 | 0.230 |
Why?
|
| Cerebral Ventricles | 1 | 2024 | 81 | 0.220 |
Why?
|
| Iatrogenic Disease | 2 | 2022 | 132 | 0.220 |
Why?
|
| Texas | 7 | 2021 | 3581 | 0.220 |
Why?
|
| Predictive Value of Tests | 5 | 2021 | 2119 | 0.220 |
Why?
|
| Pregnancy Trimester, First | 1 | 2024 | 114 | 0.220 |
Why?
|
| Postpartum Hemorrhage | 3 | 2019 | 96 | 0.210 |
Why?
|
| Stillbirth | 1 | 2023 | 80 | 0.210 |
Why?
|
| Balloon Occlusion | 1 | 2022 | 47 | 0.200 |
Why?
|
| Depression, Postpartum | 1 | 2023 | 53 | 0.200 |
Why?
|
| Amnion | 2 | 2020 | 38 | 0.200 |
Why?
|
| Aftercare | 2 | 2021 | 147 | 0.200 |
Why?
|
| Child Development | 1 | 2025 | 265 | 0.200 |
Why?
|
| Pregnancy Complications, Neoplastic | 1 | 2022 | 61 | 0.200 |
Why?
|
| Tocolytic Agents | 1 | 2021 | 12 | 0.190 |
Why?
|
| Goiter | 1 | 2021 | 7 | 0.190 |
Why?
|
| Hyperthyroidism | 1 | 2021 | 26 | 0.190 |
Why?
|
| Respiratory System Abnormalities | 1 | 2022 | 42 | 0.190 |
Why?
|
| Medical Overuse | 1 | 2021 | 25 | 0.190 |
Why?
|
| Perineum | 1 | 2021 | 48 | 0.190 |
Why?
|
| Consensus | 1 | 2024 | 628 | 0.180 |
Why?
|
| Nephrology | 1 | 2023 | 145 | 0.180 |
Why?
|
| Rhombencephalon | 1 | 2021 | 46 | 0.180 |
Why?
|
| Abortion, Spontaneous | 1 | 2022 | 79 | 0.180 |
Why?
|
| Survival Analysis | 3 | 2021 | 1482 | 0.180 |
Why?
|
| Obstetric Labor Complications | 2 | 2019 | 94 | 0.180 |
Why?
|
| Erythrocyte Transfusion | 2 | 2019 | 127 | 0.180 |
Why?
|
| Live Birth | 2 | 2020 | 54 | 0.180 |
Why?
|
| Varicose Veins | 1 | 2021 | 28 | 0.180 |
Why?
|
| Wound Closure Techniques | 1 | 2020 | 23 | 0.180 |
Why?
|
| Simulation Training | 1 | 2022 | 139 | 0.170 |
Why?
|
| Private Practice | 1 | 2020 | 22 | 0.170 |
Why?
|
| Infant, Small for Gestational Age | 1 | 2020 | 57 | 0.170 |
Why?
|
| Male | 16 | 2025 | 60964 | 0.170 |
Why?
|
| Catheters, Indwelling | 1 | 2021 | 156 | 0.170 |
Why?
|
| Intraoperative Complications | 1 | 2021 | 173 | 0.170 |
Why?
|
| alpha-Fetoproteins | 1 | 2021 | 132 | 0.170 |
Why?
|
| Ureteral Obstruction | 1 | 2021 | 105 | 0.170 |
Why?
|
| Middle Cerebral Artery | 2 | 2022 | 107 | 0.170 |
Why?
|
| Insufflation | 1 | 2020 | 20 | 0.170 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2021 | 1685 | 0.170 |
Why?
|
| Abdomen | 1 | 2020 | 127 | 0.170 |
Why?
|
| Tricuspid Valve Insufficiency | 1 | 2020 | 63 | 0.160 |
Why?
|
| Patient Care Team | 3 | 2019 | 545 | 0.160 |
Why?
|
| Vasa Previa | 1 | 2019 | 9 | 0.160 |
Why?
|
| Abortion, Induced | 1 | 2020 | 74 | 0.160 |
Why?
|
| Remission, Spontaneous | 1 | 2019 | 69 | 0.160 |
Why?
|
| Uterine Hemorrhage | 1 | 2019 | 43 | 0.160 |
Why?
|
| Sensitivity and Specificity | 1 | 2024 | 2031 | 0.160 |
Why?
|
| Health Resources | 1 | 2020 | 116 | 0.160 |
Why?
|
| Hypocalcemia | 1 | 2019 | 36 | 0.160 |
Why?
|
| Lymphatic Vessels | 1 | 2019 | 37 | 0.160 |
Why?
|
| Lung Volume Measurements | 3 | 2025 | 75 | 0.160 |
Why?
|
| Intraoperative Care | 1 | 2019 | 104 | 0.160 |
Why?
|
| Preoperative Care | 1 | 2021 | 349 | 0.160 |
Why?
|
| Fertilization in Vitro | 1 | 2020 | 146 | 0.160 |
Why?
|
| Gynecology | 1 | 2020 | 123 | 0.160 |
Why?
|
| Lymphatic Abnormalities | 1 | 2019 | 35 | 0.150 |
Why?
|
| Hypertrophy | 1 | 2018 | 101 | 0.150 |
Why?
|
| Movement Disorders | 1 | 2021 | 222 | 0.150 |
Why?
|
| Lymphangioma | 1 | 2018 | 22 | 0.150 |
Why?
|
| Nervous System Malformations | 1 | 2020 | 130 | 0.150 |
Why?
|
| Streptococcal Infections | 1 | 2021 | 244 | 0.150 |
Why?
|
| Developing Countries | 1 | 2020 | 268 | 0.150 |
Why?
|
| Placentation | 1 | 2018 | 55 | 0.150 |
Why?
|
| Lung Diseases | 1 | 2022 | 384 | 0.150 |
Why?
|
| Neck | 1 | 2019 | 137 | 0.150 |
Why?
|
| Blood Coagulation Disorders | 1 | 2019 | 101 | 0.150 |
Why?
|
| Meningitis | 1 | 2018 | 98 | 0.150 |
Why?
|
| Cerebrospinal Fluid Shunts | 1 | 2018 | 79 | 0.150 |
Why?
|
| Anesthesia | 1 | 2020 | 211 | 0.150 |
Why?
|
| Uterine Artery | 1 | 2018 | 29 | 0.150 |
Why?
|
| Labor Onset | 1 | 2017 | 4 | 0.140 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2020 | 368 | 0.140 |
Why?
|
| Gravidity | 1 | 2017 | 10 | 0.140 |
Why?
|
| Bradycardia | 1 | 2018 | 59 | 0.140 |
Why?
|
| Delayed Diagnosis | 1 | 2019 | 125 | 0.140 |
Why?
|
| MEDLINE | 1 | 2017 | 20 | 0.140 |
Why?
|
| Hypothermia | 1 | 2018 | 55 | 0.140 |
Why?
|
| Fetal Development | 1 | 2019 | 131 | 0.140 |
Why?
|
| Dystocia | 1 | 2017 | 23 | 0.140 |
Why?
|
| Trial of Labor | 1 | 2017 | 21 | 0.140 |
Why?
|
| Intensive Care Units, Neonatal | 2 | 2019 | 319 | 0.140 |
Why?
|
| Obstetrics | 1 | 2020 | 237 | 0.140 |
Why?
|
| Head and Neck Neoplasms | 2 | 2021 | 497 | 0.140 |
Why?
|
| Cystoscopy | 1 | 2017 | 44 | 0.140 |
Why?
|
| Reproductive Techniques, Assisted | 1 | 2017 | 70 | 0.140 |
Why?
|
| Laryngoscopy | 1 | 2019 | 150 | 0.140 |
Why?
|
| beta 2-Microglobulin | 1 | 2016 | 32 | 0.140 |
Why?
|
| Osmolar Concentration | 1 | 2016 | 177 | 0.130 |
Why?
|
| Ultrasonography, Interventional | 1 | 2018 | 193 | 0.130 |
Why?
|
| Anastomosis, Surgical | 1 | 2017 | 168 | 0.130 |
Why?
|
| Influenza Vaccines | 1 | 2021 | 477 | 0.130 |
Why?
|
| Pain Management | 1 | 2018 | 181 | 0.130 |
Why?
|
| Infertility, Female | 1 | 2017 | 145 | 0.130 |
Why?
|
| Chlorides | 1 | 2016 | 106 | 0.130 |
Why?
|
| Hypertension, Pulmonary | 1 | 2021 | 433 | 0.130 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2018 | 219 | 0.130 |
Why?
|
| Laparoscopy | 1 | 2021 | 489 | 0.130 |
Why?
|
| Virus Diseases | 1 | 2019 | 280 | 0.130 |
Why?
|
| Neuroimaging | 1 | 2019 | 340 | 0.130 |
Why?
|
| Interdisciplinary Communication | 1 | 2017 | 133 | 0.130 |
Why?
|
| Infant, Extremely Premature | 1 | 2016 | 84 | 0.130 |
Why?
|
| Drainage | 1 | 2017 | 258 | 0.130 |
Why?
|
| Intubation, Intratracheal | 1 | 2019 | 293 | 0.130 |
Why?
|
| Child, Preschool | 5 | 2024 | 14042 | 0.130 |
Why?
|
| Sodium | 1 | 2016 | 294 | 0.120 |
Why?
|
| Referral and Consultation | 1 | 2019 | 539 | 0.120 |
Why?
|
| Probability | 1 | 2016 | 323 | 0.120 |
Why?
|
| Influenza, Human | 1 | 2021 | 657 | 0.120 |
Why?
|
| Kidney Failure, Chronic | 1 | 2023 | 875 | 0.120 |
Why?
|
| Prognosis | 5 | 2024 | 4549 | 0.120 |
Why?
|
| Disease Management | 1 | 2018 | 519 | 0.120 |
Why?
|
| Logistic Models | 4 | 2021 | 1802 | 0.110 |
Why?
|
| Models, Theoretical | 1 | 2016 | 358 | 0.110 |
Why?
|
| Physicians | 1 | 2020 | 579 | 0.110 |
Why?
|
| Practice Guidelines as Topic | 1 | 2020 | 1254 | 0.110 |
Why?
|
| Biomedical Research | 1 | 2019 | 518 | 0.100 |
Why?
|
| Combined Modality Therapy | 1 | 2016 | 1244 | 0.100 |
Why?
|
| Organ Size | 2 | 2025 | 432 | 0.100 |
Why?
|
| Hospitals, Pediatric | 1 | 2016 | 775 | 0.100 |
Why?
|
| Decision Making | 1 | 2017 | 654 | 0.090 |
Why?
|
| Calcium | 1 | 2016 | 1095 | 0.090 |
Why?
|
| Brain | 2 | 2024 | 3003 | 0.090 |
Why?
|
| Twins | 2 | 2021 | 68 | 0.090 |
Why?
|
| Middle East | 2 | 2021 | 34 | 0.090 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2019 | 717 | 0.090 |
Why?
|
| Cerebrospinal Fluid Leak | 2 | 2021 | 43 | 0.090 |
Why?
|
| Statistics, Nonparametric | 2 | 2021 | 425 | 0.090 |
Why?
|
| Uterus | 3 | 2019 | 570 | 0.090 |
Why?
|
| Risk Assessment | 1 | 2019 | 3382 | 0.080 |
Why?
|
| Adolescent | 7 | 2022 | 19300 | 0.080 |
Why?
|
| Egypt | 2 | 2020 | 23 | 0.080 |
Why?
|
| Postoperative Period | 2 | 2020 | 333 | 0.080 |
Why?
|
| Cost-Benefit Analysis | 2 | 2021 | 511 | 0.080 |
Why?
|
| Infant Mortality | 2 | 2019 | 173 | 0.070 |
Why?
|
| Severity of Illness Index | 3 | 2020 | 2888 | 0.070 |
Why?
|
| Cross-Sectional Studies | 3 | 2021 | 3425 | 0.070 |
Why?
|
| Child | 6 | 2023 | 24435 | 0.070 |
Why?
|
| Multivariate Analysis | 2 | 2020 | 1415 | 0.060 |
Why?
|
| Rh Isoimmunization | 1 | 2024 | 28 | 0.060 |
Why?
|
| Parvoviridae Infections | 1 | 2024 | 36 | 0.060 |
Why?
|
| Pregnancy Trimesters | 1 | 2024 | 34 | 0.060 |
Why?
|
| Reproducibility of Results | 2 | 2021 | 2867 | 0.060 |
Why?
|
| Pregnancy Trimester, Third | 1 | 2024 | 117 | 0.060 |
Why?
|
| Cervix Uteri | 1 | 2023 | 63 | 0.050 |
Why?
|
| Microarray Analysis | 1 | 2023 | 230 | 0.050 |
Why?
|
| Cytomegalovirus Infections | 1 | 2024 | 218 | 0.050 |
Why?
|
| Multicenter Studies as Topic | 1 | 2023 | 273 | 0.050 |
Why?
|
| Tertiary Care Centers | 1 | 2023 | 236 | 0.050 |
Why?
|
| Maryland | 1 | 2021 | 29 | 0.050 |
Why?
|
| Fibrin | 1 | 2022 | 66 | 0.050 |
Why?
|
| Dilatation | 1 | 2022 | 66 | 0.050 |
Why?
|
| Fetal Movement | 1 | 2021 | 14 | 0.050 |
Why?
|
| Clubfoot | 1 | 2021 | 19 | 0.050 |
Why?
|
| Waist Circumference | 1 | 2021 | 88 | 0.050 |
Why?
|
| Umbilical Cord | 1 | 2021 | 56 | 0.050 |
Why?
|
| Iran | 1 | 2021 | 59 | 0.050 |
Why?
|
| Intention | 1 | 2021 | 92 | 0.050 |
Why?
|
| Encephalocele | 1 | 2021 | 52 | 0.050 |
Why?
|
| Umbilical Veins | 1 | 2021 | 71 | 0.050 |
Why?
|
| Preoperative Period | 1 | 2020 | 87 | 0.040 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 1 | 2021 | 79 | 0.040 |
Why?
|
| Middle Aged | 4 | 2021 | 26451 | 0.040 |
Why?
|
| United States | 3 | 2021 | 10766 | 0.040 |
Why?
|
| Streptococcus agalactiae | 1 | 2021 | 105 | 0.040 |
Why?
|
| Uterine Contraction | 1 | 2019 | 28 | 0.040 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2021 | 119 | 0.040 |
Why?
|
| Decision Support Techniques | 1 | 2022 | 287 | 0.040 |
Why?
|
| Time-to-Treatment | 1 | 2021 | 187 | 0.040 |
Why?
|
| Resuscitation | 1 | 2022 | 246 | 0.040 |
Why?
|
| Choroid Plexus | 1 | 2019 | 24 | 0.040 |
Why?
|
| Platelet Transfusion | 1 | 2019 | 53 | 0.040 |
Why?
|
| Risk | 1 | 2021 | 749 | 0.040 |
Why?
|
| Infant Care | 1 | 2019 | 46 | 0.040 |
Why?
|
| Maternal-Child Health Services | 1 | 2019 | 13 | 0.040 |
Why?
|
| Ventriculostomy | 1 | 2019 | 36 | 0.040 |
Why?
|
| Disseminated Intravascular Coagulation | 1 | 2019 | 67 | 0.040 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2021 | 229 | 0.040 |
Why?
|
| Perioperative Care | 1 | 2021 | 196 | 0.040 |
Why?
|
| Postnatal Care | 1 | 2019 | 51 | 0.040 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2021 | 240 | 0.040 |
Why?
|
| Workflow | 1 | 2019 | 117 | 0.040 |
Why?
|
| Plasma | 1 | 2019 | 96 | 0.040 |
Why?
|
| Parturition | 1 | 2019 | 63 | 0.040 |
Why?
|
| Academic Medical Centers | 1 | 2020 | 305 | 0.040 |
Why?
|
| Regression Analysis | 1 | 2020 | 774 | 0.040 |
Why?
|
| Cold Temperature | 1 | 2018 | 78 | 0.040 |
Why?
|
| Genetic Testing | 1 | 2024 | 1004 | 0.040 |
Why?
|
| Placenta, Retained | 1 | 2017 | 12 | 0.040 |
Why?
|
| Patient Admission | 1 | 2019 | 186 | 0.040 |
Why?
|
| Heart Rate, Fetal | 1 | 2018 | 61 | 0.040 |
Why?
|
| Term Birth | 1 | 2017 | 32 | 0.040 |
Why?
|
| Patient Positioning | 1 | 2018 | 53 | 0.040 |
Why?
|
| Oxytocics | 1 | 2017 | 28 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2021 | 1322 | 0.040 |
Why?
|
| Hepatitis B | 1 | 2019 | 160 | 0.040 |
Why?
|
| Mass Screening | 1 | 2023 | 783 | 0.040 |
Why?
|
| Maternal Age | 1 | 2017 | 132 | 0.030 |
Why?
|
| World Health Organization | 1 | 2017 | 100 | 0.030 |
Why?
|
| Clinical Decision-Making | 1 | 2019 | 266 | 0.030 |
Why?
|
| Program Evaluation | 1 | 2019 | 447 | 0.030 |
Why?
|
| Survival Rate | 1 | 2022 | 2020 | 0.030 |
Why?
|
| Isotonic Solutions | 1 | 2017 | 35 | 0.030 |
Why?
|
| Oxytocin | 1 | 2017 | 69 | 0.030 |
Why?
|
| Blood Transfusion | 1 | 2019 | 307 | 0.030 |
Why?
|
| Endoscopy | 1 | 2019 | 284 | 0.030 |
Why?
|
| Analgesics, Opioid | 1 | 2021 | 409 | 0.030 |
Why?
|
| Anxiety | 1 | 2023 | 966 | 0.030 |
Why?
|
| Maternal Exposure | 1 | 2018 | 148 | 0.030 |
Why?
|
| Emergencies | 1 | 2017 | 173 | 0.030 |
Why?
|
| Vaccination | 1 | 2021 | 953 | 0.030 |
Why?
|
| Renal Dialysis | 1 | 2023 | 850 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 2018 | 1017 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2024 | 5105 | 0.030 |
Why?
|
| Length of Stay | 1 | 2021 | 1308 | 0.030 |
Why?
|
| Stents | 1 | 2022 | 885 | 0.030 |
Why?
|
| Counseling | 1 | 2017 | 216 | 0.030 |
Why?
|
| Hepatitis C | 1 | 2019 | 364 | 0.030 |
Why?
|
| Mothers | 1 | 2018 | 353 | 0.030 |
Why?
|
| Algorithms | 1 | 2022 | 1610 | 0.030 |
Why?
|
| Inflammation | 1 | 2022 | 1414 | 0.030 |
Why?
|
| Attitude of Health Personnel | 1 | 2020 | 672 | 0.030 |
Why?
|
| Depression | 1 | 2023 | 1243 | 0.030 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2020 | 847 | 0.030 |
Why?
|
| Quality of Health Care | 1 | 2017 | 388 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2017 | 1617 | 0.030 |
Why?
|
| Disease Progression | 1 | 2019 | 2039 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 1 | 2021 | 2414 | 0.020 |
Why?
|
| HIV Infections | 1 | 2019 | 1890 | 0.020 |
Why?
|